BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14769792)

  • 1. Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells.
    Mitsutake S; Kim TJ; Inagaki Y; Kato M; Yamashita T; Igarashi Y
    J Biol Chem; 2004 Apr; 279(17):17570-7. PubMed ID: 14769792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin is involved in the Ca2+-dependent activation of ceramide kinase as a calcium sensor.
    Mitsutake S; Igarashi Y
    J Biol Chem; 2005 Dec; 280(49):40436-41. PubMed ID: 16203736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of mast cell degranulation by a novel ceramide kinase inhibitor, the F-12509A olefin isomer K1.
    Kim JW; Inagaki Y; Mitsutake S; Maezawa N; Katsumura S; Ryu YW; Park CS; Taniguchi M; Igarashi Y
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):82-90. PubMed ID: 16352467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide kinase is not essential but might act as an Ca2+-sensor for mast cell activation.
    Mitsutake S; Kumada H; Soga M; Hurue Y; Asanuma F; Nagira M; Deguchi M; Date T; Yokose U; Inagaki Y; Sugiura M; Kohama T; Igarashi Y
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):109-12. PubMed ID: 20678580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide induces serotonin release from RBL-2H3 mast cells through calcium mediated activation of phospholipase A2.
    Ji JE; Kim SK; Ahn KH; Choi JM; Jung SY; Jung KM; Jeon HJ; Kim DK
    Prostaglandins Other Lipid Mediat; 2011 Apr; 94(3-4):88-95. PubMed ID: 21236359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release.
    Pettus BJ; Bielawska A; Spiegel S; Roddy P; Hannun YA; Chalfant CE
    J Biol Chem; 2003 Oct; 278(40):38206-13. PubMed ID: 12855693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytosolic phospholipase A(2)α in cell rounding and cytotoxicity induced by ceramide-1-phosphate via ceramide kinase.
    Nakamura H; Tada E; Makiyama T; Yasufuku K; Murayama T
    Arch Biochem Biophys; 2011 Aug; 512(1):45-51. PubMed ID: 21621503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ceramide, ceramidase inhibition and expression of ceramide kinase on cytosolic phospholipase A2alpha; additional role of ceramide-1-phosphate in phosphorylation and Ca2+ signaling.
    Shimizu M; Tada E; Makiyama T; Yasufuku K; Moriyama Y; Fujino H; Nakamura H; Murayama T
    Cell Signal; 2009 Mar; 21(3):440-7. PubMed ID: 19101626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-deficient mice.
    Graf C; Zemann B; Rovina P; Urtz N; Schanzer A; Reuschel R; Mechtcheriakova D; Müller M; Fischer E; Reichel C; Huber S; Dawson J; Meingassner JG; Billich A; Niwa S; Badegruber R; Van Veldhoven PP; Kinzel B; Baumruker T; Bornancin F
    J Immunol; 2008 Mar; 180(5):3457-66. PubMed ID: 18292572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin.
    Boath A; Graf C; Lidome E; Ullrich T; Nussbaumer P; Bornancin F
    J Biol Chem; 2008 Mar; 283(13):8517-26. PubMed ID: 18086664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide inhibits IgE-mediated activation of phospholipase D, but not of phospholipase C, in rat basophilic leukemia (RBL-2H3) cells.
    Nakamura Y; Nakashima S; Ojio K; Banno Y; Miyata H; Nozawa Y
    J Immunol; 1996 Jan; 156(1):256-62. PubMed ID: 8598470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Glycerophospholipids on Ceramide Kinase Activity: Cardiolipin-Affected Cellular Formation of Ceramide-1-phosphate.
    Matsuzaki W; Takahashi H; Nakamura H; Murayama T
    Biol Pharm Bull; 2016; 39(10):1708-1717. PubMed ID: 27725450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the ceramide kinase inhibitor K1, a suppressor of mast-cell activation.
    Kumada H; Mitsutake S; Inagaki Y; Mitsunaga S; Tsuchikawa H; Katsumura S; Igarashi Y
    Biosci Biotechnol Biochem; 2007 Oct; 71(10):2581-4. PubMed ID: 17928690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ceramide-1-phosphate in biological functions.
    Hoeferlin LA; Wijesinghe DS; Chalfant CE
    Handb Exp Pharmacol; 2013; (215):153-66. PubMed ID: 23579454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of propranolol on the IgE-dependent, or calcium ionophore-stimulated, phosphoinositide hydrolysis and calcium mobilization in a mast (RBL 2H3) cell line.
    Lin PY; Wiggan GA; Welton AF; Gilfillan AM
    Biochem Pharmacol; 1991 Jun; 41(12):1941-8. PubMed ID: 1710122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBL-2H3 cells are an imprecise model for mast cell mediator release.
    Passante E; Ehrhardt C; Sheridan H; Frankish N
    Inflamm Res; 2009 Sep; 58(9):611-8. PubMed ID: 19301096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of ceramide kinase via proteasome and lysosome pathways in PC12 cells by serum withdrawal: Its protection by nerve growth factor and role in exocytosis.
    Hori M; Gokita M; Yasue M; Honda T; Kohama T; Mashimo M; Nakamura H; Murayama T
    Biochim Biophys Acta Mol Cell Res; 2020 Jul; 1867(7):118714. PubMed ID: 32246947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis.
    Lamour NF; Stahelin RV; Wijesinghe DS; Maceyka M; Wang E; Allegood JC; Merrill AH; Cho W; Chalfant CE
    J Lipid Res; 2007 Jun; 48(6):1293-304. PubMed ID: 17392267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramide kinase regulates the production of tumor necrosis factor α (TNFα) via inhibition of TNFα-converting enzyme.
    Lamour NF; Wijesinghe DS; Mietla JA; Ward KE; Stahelin RV; Chalfant CE
    J Biol Chem; 2011 Dec; 286(50):42808-17. PubMed ID: 22009748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors.
    Jolly PS; Bektas M; Watterson KR; Sankala H; Payne SG; Milstien S; Spiegel S
    Blood; 2005 Jun; 105(12):4736-42. PubMed ID: 15741218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.